✨ Health Notices




11 APRIL
NEW ZEALAND GAZETTE
1017

Health

Burial and Cremation Act 1964

Appointment of Masterton District Council to Have the Control and Management of Hastwell Cemetery

Pursuant to section 23 (3) of the Burial and Cremation Act 1964, the Governor-General has appointed the Masterton District Council to have the control and management of the Hastwell Cemetery.

Dated at Wellington this 8th day of April 2002.

RUTH DYSON, Associate Minister of Health.

go2449

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Flexetor

Active Ingredient: Fluoxetine hydrochloride 22.36mg equivalent to 20 mg fluoxetine

Dosage Form: Capsule

New Zealand Sponsor: Novartis New Zealand Limited

Manufacturers: Rolab Limited, Spartan, Kempton Park, South Africa

Rottendorf Pharma Pty Limited, Enningerloh, Germany

Product: Fludara oral

Active Ingredient: Fludarabine phosphate 10mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Schering (NZ) Limited

Manufacturer: Schering AG, Wedding, Berlin, Germany

Product: Ismo 20

Active Ingredient: Isosorbide mononitrate 20mg

Dosage Form: (VO3) Tablet

New Zealand Sponsor: Roche Products (New Zealand) Limited

Manufacturer: Roche Diagnostics GmbH, Mannheim, Germany

Dated this 6th day of April 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go2450

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Coumadin

Active Ingredient: Warfarin sodium 1mg

Dosage Form: Tablet

New Zealand Sponsor: Boots Healthcare New Zealand Limited

Manufacturer: The Boots Company Plc., Beeston, Nottingham, United Kingdom

This consent is given subject to the following condition:

● Not to be marketed as substitutable for any other warfarin product as if the 2 products were bioequivalent.

Note: This consent is valid for 2 years from 31 October 2001.

Product: Coumadin

Active Ingredient: Warfarin sodium 2mg

Dosage Form: Tablet

New Zealand Sponsor: Boots Healthcare New Zealand Limited

Manufacturer: The Boots Company Plc., Beeston, Nottingham, United Kingdom

This consent is given subject to the following condition:

● Not to be marketed as substitutable for any other warfarin product as if the 2 products were bioequivalent.

Note: This consent is valid for 2 years from 31 October 2001.



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 34


Gazette.govt.nz PDF NZ Gazette 2002, No 34





✨ LLM interpretation of page content

πŸ₯ Appointment of Masterton District Council to Manage Hastwell Cemetery

πŸ₯ Health & Social Welfare
8 April 2002
Cemetery Management, Masterton District Council, Hastwell Cemetery
  • RUTH DYSON, Associate Minister of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
6 April 2002
Medicine Distribution, New Medicines, Flexetor, Fludara oral, Ismo 20
  • G. R. BOYD, Chief Advisor, Safety and Regulation

πŸ₯ Renewal of Provisional Consent for Coumadin

πŸ₯ Health & Social Welfare
6 April 2002
Medicine Distribution, Provisional Consent, Coumadin, Warfarin sodium
  • G. R. BOYD, Chief Advisor, Safety and Regulation